Outbrain (OB) Competitors

AMERISAFE (NASDAQ:AMSF) and Outbrain (NASDAQ:OB) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Is AMSF or OB a better dividend stock?

AMERISAFE pays an annual dividend of $1.56 per share and has a dividend yield of 3.5%. Outbrain pays an annual dividend of $0.84 per share and has a dividend yield of 30.7%. AMERISAFE pays out 62.9% of its earnings in the form of a dividend. Outbrain pays out -115.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. AMERISAFE has increased its dividend for 12 consecutive years. Outbrain is clearly the better dividend stock, given its higher yield and lower payout ratio.

Which has more risk & volatility, AMSF or OB?

AMERISAFE has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, Outbrain has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500.

Is AMSF or OB more profitable?

AMERISAFE has a net margin of 19.49% compared to Outbrain's net margin of 0.39%. AMERISAFE's return on equity of 16.50% beat Outbrain's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMERISAFE	19.49%	16.50%	4.02%
Outbrain	0.39%	2.18%	0.79%

Does the MarketBeat Community favor AMSF or OB?

Outbrain received 45 more outperform votes than AMERISAFE when rated by MarketBeat users. Likewise, 60.04% of users gave Outbrain an outperform vote while only 57.04% of users gave AMERISAFE an outperform vote.

Company	Underperform	Outperform
AMERISAFE	Outperform Votes 227 57.04%	Underperform Votes 171 42.96%
Outbrain	Outperform Votes 272 60.04%	Underperform Votes 181 39.96%

Do analysts rate AMSF or OB?

AMERISAFE presently has a consensus price target of $59.50, suggesting a potential upside of 31.72%. Outbrain has a consensus price target of $7.10, suggesting a potential upside of 159.60%. Given Outbrain's higher probable upside, analysts clearly believe Outbrain is more favorable than AMERISAFE.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMERISAFE	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Outbrain	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the media favor AMSF or OB?

In the previous week, AMERISAFE had 3 more articles in the media than Outbrain. MarketBeat recorded 6 mentions for AMERISAFE and 3 mentions for Outbrain. AMERISAFE's average media sentiment score of 1.23 beat Outbrain's score of 0.63 indicating that AMERISAFE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMERISAFE	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Outbrain	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has stronger valuation and earnings, AMSF or OB?

AMERISAFE has higher earnings, but lower revenue than Outbrain. Outbrain is trading at a lower price-to-earnings ratio than AMERISAFE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMERISAFE	$301.22M	2.86	$62.11M	$2.48	18.21
Outbrain	$959.27M	0.27	$10.24M	-$0.73	-3.75

Do institutionals and insiders believe in AMSF or OB?

97.4% of AMERISAFE shares are held by institutional investors. Comparatively, 60.4% of Outbrain shares are held by institutional investors. 1.6% of AMERISAFE shares are held by company insiders. Comparatively, 12.0% of Outbrain shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

AMERISAFE beats Outbrain on 11 of the 20 factors compared between the two stocks.